Bold Capital Partners is an early-stage venture capital firm investing in life sciences, healthcare, and frontier tech companies.
Bold Capital Partners is an early-stage venture capital firm investing in life sciences, healthcare, and frontier tech companies.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Oct 15, 2022
Viome
|
Series C | $67M | Dietary Supplements | Yes |
Apr 26, 2022
Crowdz
|
Convertable Note | $10.13M | B2B | — |
Mar 9, 2022
Colossal Biosciences
|
Series A | $60M | Biotechnology | — |
Nov 10, 2021
Viome
|
Series C | $54M | Dietary Supplements | — |
May 6, 2021
Colossal Biosciences
|
Seed | $15M | Biotechnology | — |